[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100561456":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":33,"centralContacts":37,"locations":48,"responsibleParty":66,"collaborators":42,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":42,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":42,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":42,"overallStatus":51,"whyStopped":42,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Hospital for Special Surgery, New York","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Anterior Cruciate Ligament (ACL) surgeries","EXPERIMENTAL","Pediatric subjects who underwent a Anterior Cruciate Ligament (ACL) surgery and are randomized to receive either the adductor canal block (ACB) or the anterior femoral cutaneous nerve block (AFCNB).",[13,14],"Drug: Bupivacaine, Dexamethasone in Adductor Canal Block","Drug: Bupivacaine, Dexamethasone in Anterior Femoral Cutaneous Nerve Block",{"label":16,"type":10,"description":17,"interventionNames":18},"Medial Patellofemoral Ligament (MPFL) surgeries","Pediatric subjects who underwent a Medial Patellofemoral Ligament (MPFL) surgery and are randomized to receive either the adductor canal block (ACB) or the anterior femoral cutaneous nerve block (AFCNB).",[13,14],[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Bupivacaine, Dexamethasone in Adductor Canal Block","0.25% 15-20ml bupivacaine (local anesthestic) delivered as part of the adductor canal block with 2 mg preservative-free dexamethasone (corticosteroid) delivered as part of the adductor canal block",[9,16],[26],"Adductor Canal Block (ACB)",{"type":21,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Bupivacaine, Dexamethasone in Anterior Femoral Cutaneous Nerve Block","10 ml of 0.25% bupivacaine (local anesthetic) delivered as part of the anterior femoral cutaneous nerve block with 2 mg preservative-free dexamethasone (corticosteroid) delivered as part of the anterior femoral cutaneous nerve block",[9,16],[32],"Anterior Femoral Cutaneous Nerve Block (AFCNB)",[34],{"name":35,"affiliation":5,"role":36},"Kathryn DelPizzo, MD","PRINCIPAL_INVESTIGATOR",[38,44],{"name":39,"role":40,"phone":41,"phoneExt":42,"email":43},"Marko Popovic","CONTACT","646-797-8948",null,"popovicm@hss.edu",{"name":45,"role":40,"phone":46,"phoneExt":42,"email":47},"Alex Sideris, PhD","212-774-2602","Siderisa@hss.edu",[49],{"facility":50,"status":51,"city":52,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Hospital for Special Surgery","RECRUITING","New York","10021","United States","US",{"type":57,"coordinates":58},"Point",[59,60],-74.00597,40.71427,{"lat":60,"lon":59},[63],{"name":64,"role":40,"phone":42,"phoneExt":42,"email":65},"Jashvant Poeran, MD\u002FPhD","poeranj@hss.edu",{"type":67,"investigatorFullName":42,"investigatorTitle":42,"investigatorAffiliation":42,"oldNameTitle":42,"oldOrganization":42},"SPONSOR","100561456","phase-4-anterior-femoral-and-adductor-canal-nerve-blocks-in-peds-knees-100561456",false,"NCT06590402","Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees","A Pilot Study Comparing Anterior Femoral Cutaneous Nerve Blocks to Adductor Canal Blocks in Pediatric Ambulatory Knee Surgeries","Inclusion Criteria:\n\n* 8-18 years old at the time of surgery\n* Patients 40kg and above\n* ACL reconstruction of MPFL reconstruction surgery with participating surgeons\n\nExclusion Criteria:\n\n* revision surgery\n* bilateral surgery\n* general anesthesia\n* contraindications to any part of the study protocol\n* relevant pre-existing neurological deficit\n* chronic pain",true,"ALL","8 Years","18 Years",{"count":80,"type":81},60,"ESTIMATED","INTERVENTIONAL",[84],"PHASE4","The goal of this pilot clinical trial is to compare anterior femoral cutaneous nerve block (AFCN) to adductor canal block ACB) for pediatric patients undergoing either anterior cruciate ligament (ACL) or medial patellofemoral ligament (MPFL). The aims of this trial are:\n\n* To measure postoperative functional outcomes in patients who received AFCNB vs. ACB.\n* To calculate postoperative opioid requirements in pediatric knee surgeries that received AFCNB vs. ACB.\n* To calculate pain intensity levels at rest and with ambulation in patients who received AFCNB vs. ACB.\n* To quantify sensory deficits in patients who received AFCNB vs. ACB.\n* To assess patient-reported outcome measures (e.g., pain expectation scale, pain management satisfaction, PROMIS Pediatric Short Form v1.0 - Physical Activity, PROMIS Scale v1.2 - Global Health) in patients 8-18 years of age who received AFCNB vs. ACB.\n\nSubjects undergoing ACL procedures will be compared between those who received the adductor canal block to those who received the anterior femoral cutaneous nerve block. The researchers will also compare individuals who underwent MPFL procedures and received an anterior femoral cutaneous nerve block with those who received the adductor canal block.\n\nParticipants will:\n\n* Be randomized to receive either the AFCNB or ACB in addition to standard of care analgesia.\n* Maintain a patient diary to document daily pain meds\u002Fpain scores\n* Complete follow up surveys\u002Fquestionnaires via telephone and during their office visits with surgeons.",[87,88],"Anterior Cruciate Ligament Reconstruction","Medial Patellofemoral Ligament Reconstruction","2025-10-01",{"date":91,"type":92},"2025-10-06","ACTUAL",{"date":94,"type":92},"2025-06-06",{"date":96,"type":81},"2028-01",{"name":5,"class":6},1]